Dr Richard Scolyer, a distinguished pathologist known for his groundbreaking work in melanoma research, has passed away at the age of 59 following a battle with inoperable brain cancer. His family shared a heartfelt statement he wrote before his death, expressing gratitude for the support he received throughout his life and career.
A Legacy of Innovation in Cancer Treatment
Diagnosed with grade-four glioblastoma in May 2023, Dr Scolyer was confronted with the harsh prognosis of six to eight months to live. Refusing to succumb to despair, he became a pioneer in his own treatment, undergoing a series of experimental immunotherapy protocols. Remarkably, these treatments initially succeeded in slowing the progression of his cancer, allowing him to share his journey with the world and raise awareness about the disease.
In March 2025, however, Scolyer announced that his condition had deteriorated, revealing via social media that the tumour had progressed. He remained optimistic, stating, “Not the best day ever… but it’s not the end of the road and I’ve got more to do!” His resilience and tenacity resonated with many, inspiring hope and determination within both the medical community and the general public.
A Voice of Courage and Hope
Dr Scolyer’s message to Australians before his passing reflected his unwavering spirit. “I hope I have in some small way made the road ahead easier and smoother for others,” he wrote. He expressed appreciation for the encouragement he received from those he met during his travels, his online supporters, and his roots in Tasmania. His desire to be remembered as a “proud everyday Aussie” who inspired others to pursue their passions is a testament to his character.
In recognition of his contributions to cancer research, Scolyer was jointly named Australian of the Year in 2024 alongside Georgina Long, his co-medical director at Melanoma Institute Australia. Together, they were lauded for their innovative work in immunotherapy, which transformed the treatment landscape for advanced melanoma. Their research has had a profound impact on the lives of countless cancer patients, both in Australia and beyond.
National Mourning and Reflection
Prime Minister Anthony Albanese described Dr Scolyer as “one of our brightest lights and one of our biggest hearts.” He announced that a state funeral would be held to honour Scolyer’s legacy, highlighting his courage and generosity in sharing his personal battle with glioblastoma. Albanese emphasised how Scolyer’s journey exemplified the human spirit’s resilience, inspiring hope and encouraging a relentless search for solutions in the face of adversity.
Prof John Thompson from Sydney University praised Scolyer’s approachable nature and acknowledged the vast benefits his research has provided to cancer patients globally. Scolyer’s accolades include nine NSW Premier’s Awards for Outstanding Cancer Research, as well as recognition through the Order of Australia, affirming his status as a leading figure in the fight against cancer.
Why it Matters
Dr Richard Scolyer’s passing marks a significant loss not only for the field of cancer research but for the broader community that he inspired through his bravery and dedication. As a scientist who became a patient, he embodied the intersection of personal experience and professional expertise, driving home the urgency of continued innovation in cancer treatment. His legacy will undoubtedly fuel ongoing conversations about the importance of research, compassion, and hope in the face of life-altering diagnoses, reminding us all that even in the darkest times, the quest for knowledge and understanding can ignite change and inspire future generations.
